XENE Stock Price - Xenon Pharmaceuticals Inc. logo

XENE Stock Price

Xenon Pharmaceuticals Inc.

$37.44
-$0.31(-0.82%)
48
Overall
60
Value
45
Tech
39
Quality
How is this score calculated?
Market Cap
$3.68B
Volume
687.71K
52W Range
$33.38 - $72.66
Target Price
$70.26

XENE stock price is $37.44 (-0.82% on the day), giving Xenon Pharmaceuticals Inc. a market cap of $3.68B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.

XENE Stock Overview

Price
$37.44
Previous close
$37.75
Open
$37.87
Market cap
$3.68B
52-week range
$33.38 - $72.66
1-year price target
$70.26
Sector
Healthcare
Industry
Biotechnology
Exchange
Nasdaq
MarketXLS Rank
48

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

ABCD
1SymbolPriceChangeVol
2XENE$37.44-0.8%687.71K
3
4
5
6

Get Xenon Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.